Lexicon Pharma (LXRX) prices 32M-share offering at $1.30 and $41M+ private placement to fund R&D and working capital—get the key details now.
In addition to the shares being sold in the underwritten public offering, Lexicon has agreed to sell, in a concurrent private placement for expected aggregate gross proceeds of approximately $41.1 ...
They’re harnessing it to help directors prepare, debate, and decide. by Stanislav Shekshnia and Valery Yakubovich In 2014 Hong Kong–based Deep Knowledge Ventures formally appointed an algorithm to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results